% | $
Quotes you view appear here for quick access.

ImmunoGen, Inc. Message Board

  • bioimmunomabman bioimmunomabman Jul 9, 2013 10:29 AM Flag

    Options active

    Above average volume in the July 18 calls. Price started declining around the time of the trade. I can't tell if the trade was a buy, or sell, but based on the stock price reaction it appears to be a sale. Once again, IMGN can't hold above $18. It would help if the execs would stop selling shares every time the price increases. If Dan and Greg don't think IMGN has upside, they should move on. I think they have done enough damage, or failed to do anything useful for the shareholders. John Lambert (and team) are the only value creators at IMGN as far as I can see. This is getting old, just have to sell stock and calls above $18 I guess.

2.79-0.03(-1.06%)11:46 AMEDT